• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes.1型和2型糖尿病青少年中载脂蛋白B升高及致密低密度脂蛋白的患病率和决定因素
J Clin Endocrinol Metab. 2008 Mar;93(3):735-42. doi: 10.1210/jc.2007-2176. Epub 2007 Dec 18.
2
Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.血清脂质与血糖控制:青少年糖尿病SEARCH研究
Arch Pediatr Adolesc Med. 2007 Feb;161(2):159-65. doi: 10.1001/archpedi.161.2.159.
3
Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial.在 2 型糖尿病青少年中,脂质和炎症性心血管风险在 3 年内恶化:TODAY 临床试验。
Diabetes Care. 2013 Jun;36(6):1758-64. doi: 10.2337/dc12-2388.
4
Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.冠心病合并 2 型糖尿病患者低密度脂蛋白胆固醇/载脂蛋白 B 比值与富含甘油三酯脂蛋白的关系:一项横断面研究。
Cardiovasc Diabetol. 2017 Oct 2;16(1):123. doi: 10.1186/s12933-017-0606-7.
5
ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels.在低密度脂蛋白胆固醇水平控制良好的2型糖尿病患者中,载脂蛋白B/载脂蛋白A-I比值与颈动脉粥样硬化独立相关。
Korean J Intern Med. 2018 Jan;33(1):138-147. doi: 10.3904/kjim.2017.396. Epub 2017 Dec 28.
6
Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.低密度脂蛋白胆固醇与载脂蛋白 B 比值作为 2 型糖尿病患者 LDL 颗粒大小和血浆致动脉粥样硬化性的潜在指标。
Diabetes Res Clin Pract. 2021 Jun;176:108858. doi: 10.1016/j.diabres.2021.108858. Epub 2021 May 18.
7
Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.载脂蛋白 B 和非高密度脂蛋白胆固醇在 2 型糖尿病且低密度脂蛋白胆固醇控制良好的个体中显示出高致动脉粥样硬化性。
Lipids Health Dis. 2020 Jun 6;19(1):127. doi: 10.1186/s12944-020-01292-w.
8
Sex differences in the correlation between lipids related to cardiovascular risk factors and small dense LDL particles in patients with type 2 diabetes.2 型糖尿病患者中与心血管危险因素相关的脂质与小而密 LDL 颗粒之间相关性的性别差异。
Arch Endocrinol Metab. 2024 Oct 1;68:e240069. doi: 10.20945/2359-4292-2024-0069. eCollection 2024.
9
Body mass index and glycemic control influence lipoproteins in children with type 1 diabetes.体重指数和血糖控制对 1 型糖尿病患儿的脂蛋白有影响。
J Clin Lipidol. 2016 Sep-Oct;10(5):1240-7. doi: 10.1016/j.jacl.2016.07.010. Epub 2016 Aug 6.
10
Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites.在2型糖尿病白人中,载脂蛋白B而非低密度脂蛋白胆固醇与冠状动脉钙化有关。
Diabetes. 2009 Aug;58(8):1887-92. doi: 10.2337/db08-1794. Epub 2009 Jun 2.

引用本文的文献

1
Molecular and Pathophysiological Mechanisms Leading to Ischemic Heart Disease in Patients with Diabetes Mellitus.导致糖尿病患者缺血性心脏病的分子和病理生理机制。
Int J Mol Sci. 2025 Apr 22;26(9):3924. doi: 10.3390/ijms26093924.
2
Investigating the Incidence of Dyslipidemia among Brazilian Children and Adolescents Diagnosed with Type 1 Diabetes Mellitus: A Cross-Sectional Study.调查巴西1型糖尿病患儿和青少年血脂异常的发病率:一项横断面研究。
Diseases. 2024 Feb 24;12(3):45. doi: 10.3390/diseases12030045.
3
Top Five Stories of the Cellular Landscape and Therapies of Atherosclerosis: Current Knowledge and Future Perspectives.细胞景观与动脉粥样硬化治疗的五大研究热点:现状与展望。
Curr Med Sci. 2024 Feb;44(1):1-27. doi: 10.1007/s11596-023-2818-2. Epub 2023 Dec 7.
4
Associations of genetic markers of diabetes mellitus with carotid atherosclerosis: a community-based case-control study.糖尿病遗传标志物与颈动脉粥样硬化的相关性:基于社区的病例对照研究。
Cardiovasc Diabetol. 2023 Mar 9;22(1):51. doi: 10.1186/s12933-023-01787-7.
5
Youth-onset type 2 diabetes mellitus: an urgent challenge.青少年 2 型糖尿病:一个紧迫的挑战。
Nat Rev Nephrol. 2023 Mar;19(3):168-184. doi: 10.1038/s41581-022-00645-1. Epub 2022 Oct 31.
6
The Theory of Hyperlipidemic Memory of Type 1 Diabetes.1型糖尿病的高脂血症记忆理论
Front Endocrinol (Lausanne). 2022 Mar 31;13:819544. doi: 10.3389/fendo.2022.819544. eCollection 2022.
7
Lipoprotein(a) Concentrations Correlate With LDL-C in Children With Type 1 and 2 Diabetes.1型和2型糖尿病患儿的脂蛋白(a)浓度与低密度脂蛋白胆固醇相关。
J Endocr Soc. 2021 Aug 18;5(11):bvab138. doi: 10.1210/jendso/bvab138. eCollection 2021 Nov 1.
8
CARDEA study protocol: investigating early markers of cardiovascular disease and their association with lifestyle habits, inflammation and oxidative stress in adolescence using a cross-sectional comparison of adolescents with type 1 diabetes and healthy controls.CARDEA 研究方案:使用 1 型糖尿病青少年与健康对照的横断面比较,研究心血管疾病的早期标志物及其与生活方式习惯、炎症和氧化应激的关系。
BMJ Open. 2021 Sep 8;11(9):e046585. doi: 10.1136/bmjopen-2020-046585.
9
Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.载脂蛋白(a)水平与脂蛋白和载脂蛋白谱在杂合子家族性高胆固醇血症日本患者中的关系及动脉粥样硬化性疾病:家族性高胆固醇血症专家论坛(FAME)研究。
J Atheroscler Thromb. 2022 Aug 1;29(8):1188-1200. doi: 10.5551/jat.63019. Epub 2021 Aug 30.
10
Dyslipidaemia in Type 1 Diabetes: Molecular Mechanisms and Therapeutic Opportunities.1型糖尿病中的血脂异常:分子机制与治疗机遇
Biomedicines. 2021 Jul 16;9(7):826. doi: 10.3390/biomedicines9070826.

本文引用的文献

1
Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.血清脂质与血糖控制:青少年糖尿病SEARCH研究
Arch Pediatr Adolesc Med. 2007 Feb;161(2):159-65. doi: 10.1001/archpedi.161.2.159.
2
Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study.美国患有糖尿病的儿童和青少年心血管疾病风险因素的患病率:青少年糖尿病研究(SEARCH)
Diabetes Care. 2006 Aug;29(8):1891-6. doi: 10.2337/dc06-0310.
3
Gender and elevated albumin excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesity.糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究(DCCT/EDIC)队列中的性别与白蛋白排泄增加:中心性肥胖的作用
Am J Kidney Dis. 2006 Feb;47(2):223-32. doi: 10.1053/j.ajkd.2005.10.021.
4
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.非高密度脂蛋白胆固醇和载脂蛋白B在男性冠心病预测中的作用
Circulation. 2005 Nov 29;112(22):3375-83. doi: 10.1161/CIRCULATIONAHA.104.532499.
5
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus.美国国立心肺血液研究所-美国国立糖尿病、消化和肾脏疾病研究所1型糖尿病心血管并发症工作组报告
Circulation. 2005 Jun 28;111(25):3489-93. doi: 10.1161/CIRCULATIONAHA.104.529651.
6
Risk scores predict atherosclerotic lesions in young people.风险评分可预测年轻人的动脉粥样硬化病变。
Arch Intern Med. 2005 Apr 25;165(8):883-90. doi: 10.1001/archinte.165.8.883.
7
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study.男性低密度脂蛋白亚组分与缺血性心脏病的长期风险:来自魁北克心血管研究的13年随访数据。
Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):553-9. doi: 10.1161/01.ATV.0000154144.73236.f4. Epub 2004 Dec 23.
8
Early onset of subclinical atherosclerosis in young persons with type 1 diabetes.1型糖尿病青年患者亚临床动脉粥样硬化的早期发病
J Pediatr. 2004 Oct;145(4):452-7. doi: 10.1016/j.jpeds.2004.06.042.
9
SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth.青少年糖尿病研究:一项关于青少年糖尿病患病率、发病率及分类的多中心研究。
Control Clin Trials. 2004 Oct;25(5):458-71. doi: 10.1016/j.cct.2004.08.002.
10
Management of dyslipidemia in children and adolescents with diabetes.糖尿病儿童和青少年血脂异常的管理。
Diabetes Care. 2003 Jul;26(7):2194-7. doi: 10.2337/diacare.26.7.2194.

1型和2型糖尿病青少年中载脂蛋白B升高及致密低密度脂蛋白的患病率和决定因素

Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes.

作者信息

Albers John J, Marcovina Santica M, Imperatore Giuseppina, Snively Beverly M, Stafford Jeanette, Fujimoto Wilfred Y, Mayer-Davis Elizabeth J, Petitti Diana B, Pihoker Catherine, Dolan Larry, Dabelea Dana M

机构信息

Department of Medicine, Northwest Lipid Metabolism and Diabetes Research Laboratories, University of Washington, 401 Queen Anne Avenue North, Seattle, Washington 98109, USA.

出版信息

J Clin Endocrinol Metab. 2008 Mar;93(3):735-42. doi: 10.1210/jc.2007-2176. Epub 2007 Dec 18.

DOI:10.1210/jc.2007-2176
PMID:18089692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2266957/
Abstract

OBJECTIVE

The objective of the study was to assess the prevalence and determinants of elevated apolipoprotein B (apoB) and dense low-density lipoprotein (LDL) in United States youth with type 1 or type 2 diabetes.

METHODS

We conducted cross-sectional analyses of apoB concentrations, LDL density, and prevalence of elevated apoB levels and dense LDL from the SEARCH for Diabetes in Youth study, a six-center U.S.-based study of youth with diabetes onset younger than 20 years of age (2657 with type 1 and 345 with type 2).

RESULTS

Among youth with type 1 diabetes, 11% had elevated apoB (>or=100 mg/dl, 1.95 mm/liter), 8% had dense LDL (relative flotation rate<or=0.237), and 12% had elevated LDL-cholesterol (>or=130 mg/dl, 3.36 mm/liter). In contrast, among youth with type 2 diabetes, 36% had elevated apoB, 36% had dense LDL, but only 23% had elevated LDL-cholesterol. Dense LDL and apoB each increased with hemoglobin A1c in both types. Among type 1 diabetics in poor glycemic control (hemoglobin A1c>or=9.5%), 28% had elevated apoB, and 18% had dense LDL, whereas 72% of poorly controlled type 2 diabetics had elevated apoB and 62% had dense LDL.

CONCLUSIONS

In youth with type 1 diabetes, elevated apoB and dense LDL were not highly prevalent, whereas elevated apoB and dense LDL were common lipoprotein abnormalities in youth with type 2 diabetes. The prevalence of these risk factors substantially increased with poor glycemic control in both groups, stressing the importance of achieving and maintaining an optimal glucose control.

摘要

目的

本研究旨在评估1型或2型糖尿病美国青少年中载脂蛋白B(apoB)升高及致密低密度脂蛋白(LDL)的患病率和决定因素。

方法

我们对青少年糖尿病研究(SEARCH)中apoB浓度、LDL密度、apoB水平升高及致密LDL患病率进行了横断面分析,该研究是一项在美国六个中心开展的针对糖尿病发病年龄小于20岁的青少年的研究(1型糖尿病患者2657例,2型糖尿病患者345例)。

结果

在1型糖尿病青少年中,11%的患者apoB升高(≥100 mg/dl,1.95 mmol/l), 8%的患者有致密LDL(相对漂浮率≤0.237),12%的患者LDL胆固醇升高(≥130 mg/dl,3.36 mmol/l)。相比之下,在2型糖尿病青少年中,36%的患者apoB升高,36%的患者有致密LDL,但只有23%的患者LDL胆固醇升高。在两种类型的糖尿病中,致密LDL和apoB均随糖化血红蛋白升高而增加。在血糖控制不佳(糖化血红蛋白≥9.5%)的1型糖尿病患者中,28%的患者apoB升高,18%的患者有致密LDL,而在血糖控制不佳的2型糖尿病患者中,72%的患者apoB升高,62%的患者有致密LDL。

结论

在1型糖尿病青少年中,apoB升高和致密LDL并不十分普遍,而在2型糖尿病青少年中,apoB升高和致密LDL是常见的脂蛋白异常。在两组中,这些危险因素的患病率均随着血糖控制不佳而显著增加,强调了实现并维持最佳血糖控制的重要性。